ACUS:Acusphere, Inc. has been a strange story. . Wall Street doesn't think the company's drug Imagify is going to get approved. Yet, doctors are excited about the drug, and think it will be used as soon as it is approved...In the meantime, cash burn is a concern and management is going to have to figure out how to raise money yet again in 2008. So who's right? The stock is currently under $1.50 a share. Is it time for a speculative play?